Notice of Results

Syncona Limited

Notice of Final Results

20 May 2020

Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, will announce its final results for the year ended 31 March 2020 on Thursday 11 June 2020.

Syncona will publish a pre-record presentation at 7.00 am BST, followed by a Q&A session accessible via conference call or webcast at 9.30am BST. The webcast will be available on the Company's website at https://www.synconaltd.com/ or Webcast Link. Alternatively, please contact [email protected] for details of the conference call.

[ENDS]

Enquiries

Syncona Ltd

Siobhan Weaver / Annabel Clay 

Tel: +44 (0) 20 3981 7940

FTI Consulting

Ben Atwell / Natalie Garland-Collins / Tim Stamper

Tel: +44 (0) 20 3727 1000

About Syncona

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 15 - 20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. We take a long-term view, underpinned by a strategic capital base which provides us with control and flexibility over the management of our portfolio. We focus on delivering dramatic efficacy for patients in areas of high unmet need.